Comparison of transflection and transmission FTIR imaging measurements performed on differentially fixed tissue sections

Literature Information

Publication Date 2015-02-03
DOI 10.1039/C4AN02034K
Impact Factor 4.616
Authors

Miguel de la Guardia, Matti Kiupel, Bayden R. Wood


View Original

Abstract

The widespread and cost-effective use of transflection substrates in Fourier transform infrared (FTIR) imaging of clinical samples is affected by the presence of artefacts including the electric field standing wave (EFSW) and contributions from light dispersion. For IR-based diagnostics, the manifestation of undesirable artifacts can distort the spectra and lead to erroneous diagnosis. Nevertheless, there is no clear consensus in the literature about the degree of influence of these effects. The aim of this work is to contribute to this discussion by comparing transflection and transmission images of the same tissue. For this purpose two adjacent sections of the same tissue (lymphoma sample) were fixed onto a CaF2 window and a transflective slide for FTIR imaging. The samples in this case had a central area where based on morphology it was presumed the fixative did not penetrate to the same extent hence providing a comparable region for the two different substrates with a distinct physical/chemical difference. Transmission and transflection spectra from adjacent hyperspectral tissue images were combined in an extended dataset. Surprisingly, unsupervised hierarchical cluster analysis clustered together transflection and transmission spectra, being classified according to differences in tissue fixation instead of the geometry employed for the image acquisition. A more detailed examination of spectra from the peripheral zone of the tissue indicated that the main differences between the transflection and transmission spectra were: (1) a small shift of the amide I, (2) a larger “noise” component in the transflection spectra requiring more averaging to obtain representative spectra of tissue types, and (3) the phosphate bands were generally higher in absorbance in the transflection measurements compared to the transmission ones. The amide I shift and the larger spectral variance was consistent with results obtained in previous studies where the EFWS was present. The findings indicate that artifacts resulting from transflection measurements were small but consistent across the tissue, and therefore the use of transflection measurements could be employed for disease diagnosis. Accordingly, we recommend a straightforward multivariate comparison of images from transmission and transflection measurements in a combined data matrix obtained from adjacent sections of the tissue as a useful preliminary study for establishing the impact of the EFWS on the samples, before considering the routine use of transflection substrates for any new tissue studied.

Related Literature

Enclathration of morpholinium cations by Dianin's compound: salt formation by partial host-to-guest proton transfer

Gareth O. Lloyd, Martin W. Bredenkamp, Leonard J. Barbour

2005-07-13 Communication

DOI: 10.1039/B507726E

Lower rim mono-functionalization of resorcinarenes

Frank Hauke, Andrew J. Myles, Julius Rebek Jr.

2005-07-25 Communication

DOI: 10.1039/B506048F

The synthesis of tris(perfluoroalkyl)phosphines

Makeba B. Murphy-Jolly, Lesley C. Lewis, Andrew J. M. Caffyn

2005-08-08 Communication

DOI: 10.1039/B507752D

Synthesis of 1,3-dioxo-hexahydropyrido[1,2-c][1,3]diazepine carboxylates, a new bicyclic skeleton formed by ring expansion–RCM methodology

Nicolai Dieltiens, Diederica D. Claeys, Bart Allaert, Francis Verpoort, Christian V. Stevens

2005-08-04 Communication

DOI: 10.1039/B508663A

PNA C–C+i-motif: superior stability of PNA TC8 tetraplexes compared to DNA TC8 tetraplexes at low pH

Nagendra K. Sharma, Krishna N. Ganesh

2005-07-13 Communication

DOI: 10.1039/B506870C

Solid-state 87Rb NMR signatures for rubidium cations bound to a G-quadruplex

Ramsey Ida, Gang Wu

2005-08-02 Communication

DOI: 10.1039/B505674H

Contents

Front/Back Matter

DOI: 10.1039/B510673G

Water-soluble organic dppz analogues—tuning DNA binding affinities, luminescence, and photo-redox properties

Tim Phillips, Chatna Rajput, Lance Twyman, Ihtshamul Haq, Jim A. Thomas

2005-07-27 Communication

DOI: 10.1039/B506946G

You might also like

Compound Q&A

How should waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3) be handled?

Waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3...

898825-89-3N-Methoxy-N-methyl-1...
Compound Q&A

How should N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine (CAS: 1318338-47-4) be stored?

N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine should be stored in a tightly sealed c...

1318338-47-4N-(4-Biphenylyl)dibe...
Compound Q&A

What is the market or research trend for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1)?

The market for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1) is...

1713-07-13-Acetamido-5-amino-...
Compound Q&A

How should Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) be stored?

Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) ...

61820-03-9Benzyl 2-O-acetyl-3,...
Compound Q&A

What regulatory guidelines apply to 2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3)?

2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3) is regulated under the Glob...

438050-52-32-Ethylpiperazine di...
Compound Q&A

What regulatory guidelines apply to 1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 119462-56-5)?

1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 11946...

119462-56-51,1'-[1,3-Phenyleneb...
Compound Q&A

Are there alternatives to 5-Fluoro-2-(1-pyrrolidinyl)pyridine (CAS: 1287217-79-1) in synthesis?

Several alternatives can be used in the synthesis of 5-Fluoro-2-(1-pyrrolidinyl)...

1287217-79-15-Fluoro-2-(1-pyrrol...
Compound Q&A

What precautions should be taken when handling 6-Bromoimidazo[1,2-a]pyridin-8-amine (CAS: 676371-00-9)?

When handling 6-Bromoimidazo[1,2-a]pyridin-8-amine, it is important to wear appr...

676371-00-96-Bromoimidazo[1,2-a...
Compound Q&A

Are there alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochloride (CAS: 1049740-22-8) in synthesis?

Alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochlo...

1049740-22-8(2S,4R)-4-(4-Nitrobe...

Source Journal

Analyst

Analyst
CiteScore: 7.8
Self-citation Rate: 5.6%
Articles per Year: 653

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.